Try our beta test site
314 studies found for:    Northwestern AND urology
Show Display Options
Rank Status Study
1 Active, not recruiting Antibiotic Prophylaxis for Transrectal Prostate Biopsy
Condition: Infection
Interventions: Drug: Ciprofloxacin;   Drug: trimethoprim-sulfamethoxazole;   Drug: cefuroxime;   Drug: ceftriaxone;   Drug: gentamicin;   Drug: amikacin;   Drug: aztreonam;   Drug: imipenem
2 Recruiting The SLIM Study: Sling and Botox® Injection for Mixed Urinary Incontinence
Conditions: Mixed Urinary Incontinence;   Stress Urinary Incontinence;   Urgency Incontinence
Interventions: Drug: OnabotulinumtoxinA (Botox ®) Injections;   Drug: Saline Injections
3 Recruiting Chemokine Mechanisms in Chronic Pelvic Pain
Conditions: Chronic Prostatitis With Chronic Pelvic Pain Syndrome;   Prostatitis
Intervention:
4 Active, not recruiting Restricted Convalescence: Outcomes Following Urogynecologic Procedures
Condition: Pelvic Organ Prolapse
Interventions: Other: liberal postoperative activity;   Other: Restricted postoperative activity
5 Recruiting Belatacept 3 Month Post Transplant Conversion Study
Conditions: Transplant; Failure, Kidney;   EBV
Interventions: Drug: belatacept;   Drug: Tacrolimus;   Drug: MPA
6 Active, not recruiting Study in Recipients of Renal Transplant Allograft to Evaluate the Impact of Two Immunosuppressive Regimens
Condition: End Stage Renal Failure With Renal Transplant
Interventions: Drug: Tacrolimus with MMF;   Drug: Group 2: Tacrolimus with Everolimus.
7 Recruiting Combined Spinal Epidural Urinary Retention
Conditions: Anesthesia;   Pain;   Urinary Retention
Interventions: Device: Foley catheter placement;   Other: Spontaneous Micturation/ Post Void Residual
8 Enrolling by invitation Quality of Life in Pre and Post Renal Transplant in Hispanic and Non-Hispanic Recipients
Condition: Transplant; Failure, Kidney
Intervention:
9 Terminated A Pilot Study to Assess the Safety and Efficacy of Alefacept in de Novo Kidney Transplant Recipients
Condition: Transplant; Failure, Kidney
Intervention: Drug: Alefacept (ASP0485)
10 Completed Optimizing Kidney Transplant Informed Consent
Condition: End-stage Kidney Disease
Intervention: Behavioral: Inform Me: web-based education tool
11 Completed Evaluation of a Website on Living Kidney Donation for Hispanics
Condition: End Stage Kidney Disease
Intervention: Behavioral: Website Intervention
12 Withdrawn Pharmacokinetic Assessment of Peramivir in Hospitalized Adults Undergoing Continuous Renal Replacement Therapy
Conditions: Influenza;   Renal Failure
Intervention:
13 Withdrawn Study of a Drug [DCVax (tm)-Prostate] to Treat Prostate Cancer When Hormone Therapy is no Longer Effective.
Condition: Prostate Cancer
Intervention: Drug: Dendritic cell immunotherapy
14 Completed Lung Function After Robot-assisted Radical Prostate Ectomy
Condition: Lung Function
Interventions: Device: AirSeal;   Device: Olympus UHI-3
15 Recruiting Trans-MAPP II Study of Urologic Chronic Pelvin Pain
Conditions: Interstitial Cystitis;   Chronic Prostatitis
Intervention:
16 Withdrawn Pharmacokinetic Assessment of Ceftazidime in Intermittent Hemodialysis Patients
Condition: Renal Failure
Intervention: Other: pharmacokinetic monitoring
17 Completed Lidocaine and Prevention of Chronic Pain
Condition: Surgery
Interventions: Drug: .9 normal saline placebo;   Drug: Group L (lidocaine)
18 Active, not recruiting Trial of Adoptive Immunotherapy With TRACT to Prevent Rejection in Living Donor Kidney Transplant Recipients
Condition: End Stage Renal Disease
Intervention: Drug: Expanded Tregs
19 Active, not recruiting Induction of Donor Specific Tolerance in Recipients of Living Kidney Allografts by Donor FCRx Infusion
Condition: Kidney Failure
Intervention: Biological: Enriched Hematopoietic Stem Cell Infusion
20 No longer available Induction of Donor-Specific Tolerance in Recipients of Live Donor Stem Cell Infusion (Compassionate Use)
Condition: Renal Failure
Intervention: Biological: Biological/Vaccine: Enriched Hematopoetic Stem Cell Infusion

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.